Company Overview
- Headquarters
- 33 Arch Street Suite 3201, Boston MA
- Website
- argenx.com
- Phone
- (324) 777-7294
- Employees
- 1,512
- Founded in
- 2008
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$1,000B
Who is argenx
Argenx is a global company based in Boston, Massachusetts, specializing in the development and commercialization of antibody-based medicines for the treatment of severe autoimmune diseases. With a workforce of 1,512 employees, Argenx has achieved a revenue of $1 billion. The company focuses on developing and delivering innovative antibody therapies to address unmet medical needs in the field of immunology. Their product portfolio encompasses a range of novel treatments designed to target specific immune system pathways involved in autoimmune disorders. Argenx's therapies aim to improve the lives of patients suffering from debilitating conditions. A key aspect of Argenx's approach is its commitment to scientific collaboration. Through its Immunology Innovation Program (IIP), the company partners with leading academic researchers to translate cutting-edge immunology discoveries into tangible therapeutic solutions. This collaborative model fosters innovation and accelerates the development of novel antibody-based medicines. For more information about Argenx and its innovative therapies, please visit their website at argenx.com.
Company Leadership
argenx Industry Tags
argenx Tech Stack
Companies Similar to argenx
Analyze industry trends and opportunities by examining competitors and companies comparable to argenx, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 1,000M | 2,668 | Minneapolis, MN | 1981 | |
| 1,000M | 31 | |||
| 1,000M | 11,659 | Wayne, PA | 1904 | |
| 1,000M | 24 | Mountain View, CA | 1999 | |
| 1,000M | 54 |